Summary

• Page properties (1 modified, 0 added, 0 removed)

Details

Page properties

Content

...	...	@@ -25,7 +25,11 @@
25	25	= Recent Developments =
26	26
27	27	* On May 22, 2023, the Company entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with American International Group, Inc. (together with its affiliates and subsidiaries, “AIG”) pursuant to which, upon the terms and subject to the conditions thereof, the Company agreed to purchase certain direct and indirect subsidiaries of AIG, including Validus Holdings, Ltd., Validus Specialty, LLC, and Validus Reinsurance, Ltd. (the acquisitions under the Stock Purchase Agreement, together with the other transactions contemplated thereby, the “Validus Acquisition”). The Validus Acquisition, which is currently expected to close during the fourth quarter of 2023, is subject to customary closing conditions, including, among others, receipt of required regulatory approvals.{{footnote}}https://cbonds.com/news/2329972/{{/footnote}}
28		-* Completed acquisition of Validus Re from American International Group, Inc.(AIG) on November 1, 2023.{{footnote}}https://www.insurancejournal.com/news/international/2023/11/01/746483.htm{{/footnote}}
	28	+* Completed acquisition of Validus Re from American International Group, Inc.(AIG) on November 1, 2023.{{footnote}}https://www.insurancejournal.com/news/international/2023/11/01/746483.htm{{/footnote}} AIG received total consideration of $3.3 billion in cash, including a pre-closing dividend, and approximately $275 million in RenaissanceRe common shares. The deal, which was announced on May 22, 2023, includes Validus Reinsurance Ltd. and its consolidated subsidiaries, AlphaCat Managers Ltd., and all renewal rights to the Assumed Reinsurance Treaty Unit of Talbot (together known as Validus Re).
29	29
	30	+= Recent Financing Activities =
30	30
	32	+* On May 26, 2023, the Company completed an offering of 7,245,000 of common shares at the public offering price of $192.00 per share. The Company received net proceeds of approximately $1,352.0 million from the offering of common shares after deducting the underwriting discounts and estimated offering expenses payable.
	33	+
	34	+
31	31	{{putFootnotes/}}